PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
26-Mar-2020 Inzomelid completes Phase I studies and shows positive results in the treatment of Cryopyrin-Associated Periodic Syndrome (CAPS) Inflazome
26-Mar-2020 Lokelma approved in Japan for the treatment of hyperkalaemia AstraZeneca
26-Mar-2020 Government to provide free car parking for NHS and social care staff GOV.UK
26-Mar-2020 Castor launches COVID-19 monitoring and research platform and is supporting over 50 trials globally Castor
26-Mar-2020 Insilico Biotechnology AG incorporates Singapore subsidiary Insilico Biotechnology AG
26-Mar-2020 Independent site management organisation Panthera prepares for COVID-19 Panthera Biopartners
26-Mar-2020 Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19 Grifols
26-Mar-2020 AMI’S POLYMER SUPPLY CHAIN CONFERENCE 2020 POSTPONED AMI
26-Mar-2020 ISCT stands against organisations marketing unproven COVID-19 CGTs The International Society for Cell & Gene Therapy (ISCT)
25-Mar-2020 TRANSPARENT PEER REVIEW COMES TO ROYAL SOCIETY OF CHEMISTRY Royal Society of Chemistry
25-Mar-2020 1 week to go to SMi’s 22nd Annual Superbugs & Superdrugs Conference  SMi Group
23-Mar-2020 Synairgen to start trial of SNG001 in COVID-19 imminently Synairgen plc
23-Mar-2020 Helsinn announces European approval of the IV formulation of AKYNZEO® (fosnetupitant / palonosetron) Helsinn Group
23-Mar-2020 Syncona Limited Business Update Syncona Limited
23-Mar-2020 All patients in the European MOB-015 Phase 3 study have completed their last visit Moberg Pharma AB
23-Mar-2020 Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates BONE THERAPEUTICS
23-Mar-2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy Vaccitech
23-Mar-2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy Vaccitech Limited
23-Mar-2020 Immutep’s partner, EOC Pharma, reports completion of recruitment of phase I study of Efti Immutep
23-Mar-2020 INVESTIGATION REVEALS £21 MILLION NHS BILL FOR AVOIDABLE DEFICIENCIES IN HEART FAILURE BMJ journal